Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Devroey

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Fertility and Sterility|March 7, 2003
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilizationNicole G M Beckers, Nicholas S Macklon, Paul Devroey, et al.
Fertility and Sterility|June 9, 2007
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transferEvangelos G Papanikolaou, Efstratios M Kolibianakis, Cristina Pozzobon, et al.
Human Reproduction (Oxford, England)|December 22, 2012
Human trophectoderm cells are not yet committedCaroline De Paepe, Greet Cauffman, An Verloes, et al.
Fertility and Sterility|June 29, 2010
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trialEvangelos G Papanikolaou, Human Fatemi, Michel Camus, et al.
Fertility and Sterility|February 18, 2004
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cyclesKostantinos Zikopoulos, Efstratios M Kolibianakis, Michael Camus, et al.
Human Reproduction (Oxford, England)|October 9, 2004
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trialCatherine Staessen, Peter Platteau, Elvire Van Assche, et al.
Human Reproduction (Oxford, England)|January 30, 2009
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expressionInge Van Vaerenbergh, Leentje Van Lommel, Vanessa Ghislain, et al.
Fertility and Sterility|January 18, 2006
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cyclesEvangelos G Papanikolaou, Cristina Pozzobon, Efstratios M Kolibianakis, et al.
Human Reproduction (Oxford, England)|August 2, 2005
Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective studyEvangelos G Papanikolaou, Elke D'haeseleer, Greta Verheyen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5Christophe Blockeel, Monique D Sterrenburg, Frank J Broekmans, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Fertility and Sterility|March 7, 2003
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilizationNicole G M Beckers, Nicholas S Macklon, Paul Devroey, et al.
Fertility and Sterility|June 9, 2007
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transferEvangelos G Papanikolaou, Efstratios M Kolibianakis, Cristina Pozzobon, et al.
Human Reproduction (Oxford, England)|December 22, 2012
Human trophectoderm cells are not yet committedCaroline De Paepe, Greet Cauffman, An Verloes, et al.
Fertility and Sterility|June 29, 2010
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trialEvangelos G Papanikolaou, Human Fatemi, Michel Camus, et al.
Fertility and Sterility|February 18, 2004
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cyclesKostantinos Zikopoulos, Efstratios M Kolibianakis, Michael Camus, et al.
Human Reproduction (Oxford, England)|October 9, 2004
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trialCatherine Staessen, Peter Platteau, Elvire Van Assche, et al.
Human Reproduction (Oxford, England)|January 30, 2009
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expressionInge Van Vaerenbergh, Leentje Van Lommel, Vanessa Ghislain, et al.
Fertility and Sterility|January 18, 2006
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cyclesEvangelos G Papanikolaou, Cristina Pozzobon, Efstratios M Kolibianakis, et al.
Human Reproduction (Oxford, England)|August 2, 2005
Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective studyEvangelos G Papanikolaou, Elke D'haeseleer, Greta Verheyen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 11, 2011
Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5Christophe Blockeel, Monique D Sterrenburg, Frank J Broekmans, et al.
Pageof 19